ATE323508T1 - Synthetische virus-ähnliche partikel mit heterologen epitopen. - Google Patents

Synthetische virus-ähnliche partikel mit heterologen epitopen.

Info

Publication number
ATE323508T1
ATE323508T1 AT99967294T AT99967294T ATE323508T1 AT E323508 T1 ATE323508 T1 AT E323508T1 AT 99967294 T AT99967294 T AT 99967294T AT 99967294 T AT99967294 T AT 99967294T AT E323508 T1 ATE323508 T1 AT E323508T1
Authority
AT
Austria
Prior art keywords
particles
synthetic virus
heterologue
epitopes
useful
Prior art date
Application number
AT99967294T
Other languages
English (en)
Inventor
Kathrin U Jansen
Jessica C Ling
Steven W Ludmerer
William L Mcclements
Xin-Min Wang
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE323508T1 publication Critical patent/ATE323508T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20023—Virus like particles [VLP]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT99967294T 1998-12-17 1999-12-14 Synthetische virus-ähnliche partikel mit heterologen epitopen. ATE323508T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11261098P 1998-12-17 1998-12-17

Publications (1)

Publication Number Publication Date
ATE323508T1 true ATE323508T1 (de) 2006-05-15

Family

ID=22344867

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99967294T ATE323508T1 (de) 1998-12-17 1999-12-14 Synthetische virus-ähnliche partikel mit heterologen epitopen.

Country Status (7)

Country Link
EP (1) EP1140161B1 (de)
AT (1) ATE323508T1 (de)
AU (1) AU770809B2 (de)
CA (1) CA2354444A1 (de)
DE (1) DE69930960T2 (de)
ES (1) ES2262359T3 (de)
WO (1) WO2000035479A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1947174A1 (de) * 2000-06-21 2008-07-23 MedImmune, LLC Chimärische menschliche Papillomavirus-L1-Moleküle und Verwendungen davon
US6908613B2 (en) * 2000-06-21 2005-06-21 Medimmune, Inc. Chimeric human papillomavirus (HPV) L1 molecules and uses therefor
DE10137102A1 (de) * 2001-07-30 2003-02-27 Deutsches Krebsforsch Polyvalente Vakzine gegen durch Papillomaviren verursachte Erkrankungen, Verfahren zu deren Herstellung und deren Verwendung
US7955603B2 (en) 2006-09-29 2011-06-07 Ligocyte Pharmaceuticals, Inc. Norovirus vaccine formulations
SG10201601660YA (en) 2007-09-18 2016-04-28 Takeda Vaccines Inc Method of conferring a protective immune response to norovirus
JP5852883B2 (ja) * 2008-08-08 2016-02-03 タケダ ワクチン，インコーポレイテッド 交差反応性の増強のための複合カプシドアミノ酸配列を含むウイルス様粒子
AU2012282658B2 (en) 2011-07-11 2014-11-27 Takeda Vaccines, Inc. Parenteral norovirus vaccine formulations
CN114539363B (zh) * 2020-11-26 2023-12-01 中国医学科学院基础医学研究所 一种c端改造的人乳头瘤病毒11型l1蛋白及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618536A (en) * 1992-09-03 1997-04-08 The United States Of America As Represented By The Department Of Health And Human Services Chimeric papillomavirus-like particles
US5437951A (en) * 1992-09-03 1995-08-01 The United States Of America As Represented By The Department Of Health And Human Services Self-assembling recombinant papillomavirus capsid proteins
AUPM566794A0 (en) * 1994-05-17 1994-06-09 University Of Queensland, The Process and product
US5795754A (en) * 1995-07-19 1998-08-18 Merck & Co., Inc. Synthetic HPV11 virus-like particles
JP2000501285A (ja) * 1995-11-15 2000-02-08 メルク エンド カンパニー インコーポレーテッド 合成ｈｐｖ１１ウイルス様粒子
US5922588A (en) * 1996-10-04 1999-07-13 Merck & Co., Inc. Synthetic HPV16 virus-like particles

Also Published As

Publication number Publication date
EP1140161B1 (de) 2006-04-19
DE69930960T2 (de) 2007-04-19
ES2262359T3 (es) 2006-11-16
CA2354444A1 (en) 2000-06-22
AU770809B2 (en) 2004-03-04
DE69930960D1 (de) 2006-05-24
EP1140161A1 (de) 2001-10-10
AU2360000A (en) 2000-07-03
WO2000035479A1 (en) 2000-06-22
EP1140161A4 (de) 2003-05-02

Similar Documents

Publication Publication Date Title
WO2000015251A3 (de) Influenzavirus-impfstoffzusammensetzung
ES2078375T3 (es) Polimero isobutileno que tiene un grupo insaturado y su preparacion.
BR0108711A (pt) Expressão heteróloga de proteìnas de neisseria
ES2170743T3 (es) Oxido de aluminio preparado por via pirogena.
DE60233029D1 (de) "hyperblebbing" bakterielle stämme und ihre verwendung zur herstellung von impfstoffen
ATE489968T1 (de) Proteosom-liposaccharid-vakzine-adjuvans
DE69535018D1 (de) Papillomavirus vakzine
ECSP045300A (es) Antígenos virales
EP1611897A3 (de) Intakte oder zerstörte Insektenzellen als Antigenadjuvant
CY1111552T1 (el) Χρηση hpv16 και hpv18 ως εμβολιο εναντι ενος ή περισσοτερων ογκογονικου hpv τυπου 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68
DK1183332T3 (da) Porcint Reproduktions- og Respirations Syndrom-vaccine baseret på isolere JA-142
JP2002525392A5 (de)
ATE323508T1 (de) Synthetische virus-ähnliche partikel mit heterologen epitopen.
NO20050721L (no) HSP70 fra Arthrobacter
PT1159968E (pt) Estirpes atenuadas de vírus do dengue e a sua utilização numa composição de vacina
ATE375514T1 (de) Zusammensetzungen und methoden zur detektion einer trypanosoma cruzi infektion
ATE258222T1 (de) Synthetische hpv11 virusartige partikel
BR0009077A (pt) Antìgenos de tuberculose e métodos de uso dos mesmos
DE3888887D1 (de) Monoklonale Antikörper gegen E7-Protein des Humanen Papillomvirus Typ 16, Verfahren zu ihrer Herstellung sowie ihre Verwendung.
DE69727830T2 (de) Synthetische hpv-16 virusähnliche partikel
IT1229226B (it) Procedimento e composizione per ridurre la permeabilita' di una zona ad alta permeabilita' in un giacimento petrolifero.
EP1849800A3 (de) Moraxella catarrhalis-Proteine
DE68927340D1 (de) Biologischer impfstoff, wirksam gegen aphanomyces
ATE125866T1 (de) Typ ii-restriktionsendonuklease swai.
AU635124B2 (en) Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and prevention thereof as vaccines

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties